London, 24 May 2024: Scientists have used breast cancer cells' weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumours.

 

Related News

• Study Identifies Hundreds of Potential Targets for Cancer Drugs (12-09-2024)

---

• Protein-lipid particles to deliver genetic medicine (11-09-2024)

---

• Harnessing bacteriophages as targeted treatments for drug-resistant bacteria (06-09-2024)

---

• Chinese scientists claim to have developed hydrogel to treat arthritis: Report (03-09-2024)

---

• Human gut microbiome: A source of new antibiotic peptides (26-08-2024)

---

• IIT Kanpur-KGMU together developed a special device, to give easily CPR at home (01-08-2024)

---

• Scientists control bacterial mutations to preserve antibiotic effectiveness (27-07-2024)

---

• Dual action antibiotic could make bacterial resistance nearly impossible (25-07-2024)

---

• Metoprolol, Tamsulosin and Bromocriptine combination treatment shows promise in the treatment of retinal degenerations (23-07-2024)

---

• Rotifer acquire genes from bacteria that can produce antibiotics (21-07-2024)

---